Catfish (Silurus asotus) lectin enhances the cytotoxic effects of doxorubicin

Yakugaku Zasshi

Volumn 125, Issue 3, 2005, Pages 327-334

  Sugawara, Shigeki ^a   Sasaki, Satoko ^a   Ogawa, Yukiko ^a   Hosono, Masahiro ^a   Nitta, Kazuo ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cell permeability; Doxorubicin; Globotriaosylceramide; Rhamnose binding lectins

Indexed keywords

DOXORUBICIN; GLOBOTRIAOSYLCERAMIDE; LECTIN; LIPOCORTIN 5; PROPIDIUM IODIDE; RHAMNOSE BINDING LECTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATFISH; CELL CULTURE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL SIZE; CELL STRAIN K 562; CELL SURFACE; CULTURE MEDIUM; DAUDI CELL; DRUG BINDING; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG PENETRATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RAJI CELL; TUMOR CELL LINE;

ANIMALS; ANNEXIN A5; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DOXORUBICIN; DRUG SYNERGISM; FISH PROTEINS; HUMANS; LECTINS; MICE; NEOPLASMS; PROPIDIUM; RABBITS; TRIHEXOSYLCERAMIDES; TUMOR CELLS, CULTURED;

EID: 18244400104     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.125.327     Document Type: Article

References (23)

1. Gabius H. J., Eur. J. Biochem., 243, 543-576 (1997).
2. Drickamer K., J. Biol. Chem., 263, 9557-9560 (1988).
3. Barondes S. H., Cooper D. N. W., Gitt M. A., Leffler H., J. Biol. Chem., 269, 20807-20810 (1994).
4. Powell L. D., Varki A., J. Biol. Chem., 270, 14243-14246 (1995).
5. Margalit H., Fischer N., Ben-Sasson S. A., J. Biol. Chem., 268, 19228-19231 (1993).
6. Teichberg V. I., Silman I., Beitsch D. D., Resheff G., Proc. Natl. Acad. Sci. U.S.A., 72, 1383-1387 (1975).
7. Muramoto K., Kagawa D., Sato T., Ogawa T., Nishida Y., Kamiya H., Comp. Biochem. Physiol. B, 123, 33-45 (1999).
8. Tasumi S., Ohira T., Kawazoe H., Suetake H., Suzuki Y., Aida K., J. Biol. Chem., 277, 27305-27311 (2002).
9. Hosono M., Kawauchi H., Nitta K., Takayanagi Y., Shiokawa H., Mineki R., Murayama K., Biol. Pharm. Bull., 16, 1-5 (1993).
10. Hosono M., Ishikawa K., Mineki R., Murayama K., Numata C., Ogawa Y., Takayanagi Y., Nitta K., Biochim. Biophys. Acta, 1472, 668-675 (1999).
11. Hosono M., Matsuda K., Kawauchi H., Takayanagi Y., Shiokawa H., Mineki R., Murayama K., Nitta K., Biomed. Res., 13, 443-449 (1992).
12. Tateno H., Saneyoshi A., Ogawa T., Muramoto K., Kamiya H., Saneyoshi M., J. Biol. Chem., 273, 19190-19197 (1998).
13. Shiina N., Tateno H., Ogawa T., Muramoto K., Saneyoshi M., Kamiya H., Fish. Sci., 68, 1352-1366 (2002).
14. Sugawara S., Hosono M., Ogawa Y., Takayanagi M., Nitta K., Trends Glycosci. Glycotech., 16 (Suppl.), S46 (2004).
15. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C., J. Immunol. Methods, 184, 39-51 (1995).
16. Furukawa K., Yokoyama K., Sato T., Wiels J., Hirayama Y., Ohta M., Furukawa K., J. Biol. Chem., 277, 11247-11254 (2002).
17. Taguchi T., Uchida H., Kiyokawa N., Mori T., Sato N., Horie H., Takeda T., Fujimoto J., Kidney Int., 53, 1681-1688 (1998).
18. Lingwood C., Law H., Richardoson S., Petric M., Buruton J. L., Grandis S. D., Karmali M., J. Biol. Chem., 262, 8834-8839 (1987).
19. "The Metabolic and Molecular Bases of Inherited Disease," 7th ed., eds. by Scriver C. R., Beaudet A. L., Sly W. S., Valle D., McGraw-Hill, New York, 1995.
20. Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M., J. Immunol., 148, 2207-2216 (1992).
21. Sugawara S., Hosono M., Ogawa Y., Takayanagi M., Nitta K., Biol. Pharm. Bull., 28, 434-441 (2005).
22. Hoffmann E. K., Alfred Benzon Symp., 11, 397-417 (1978).
23. Hoffmann E. K., Dunham P. B., Int. Rev. Cytol., 161, 173-262 (1995).